Fundraising Fox

Alexander Pasteur

Investor

Partner at F-Prime Capital Partners

United Kingdom

Writes $100K – $10M checks Β· typically $5M

About

Alex Pasteur is a Partner at F-Prime, which he joined in 2012, and concentrates on therapeutics and life sciences investments. He has worked in healthcare investing since 2001, including a prior role at MVM Life Science Partners LLP in the USA and Europe. He holds an M.A. in Natural Sciences and a PhD in Chemistry, both from Cambridge University.

Invests in

BiotechDigital Health

Experience

  1. F-Prime Capital PartnersPartnercurrent2012 β€” presentLondon, United Kingdom
  2. Tenpoint Therapeutics, Ltd.Non Executive Directorcurrent2020 β€” presentLondon, England, United Kingdom
  3. NodTheraNon Executive Directorcurrent2018 β€” presentBoston, Massachusetts, United States
  4. GenomicsNon Executive Directorcurrent2018 β€” presentOxford, England, United Kingdom
  5. PeptoneNon Executive Directorcurrent2022 β€” presentLondon Area, United Kingdom
  6. PulmocideNon Executive Directorcurrent2013 β€” presentLondon, United Kingdom
  7. Shift BioscienceNon Executive Directorcurrent2022 β€” present
  8. CastorBoard Observercurrent2021 β€” presentAmsterdam, North Holland, Netherlands
  9. ARTBIONon Executive Directorcurrent2021 β€” presentBoston, MA
  10. OwkinNon Executive Directorcurrent2019 β€” presentParis
  11. OvivaNon Executive Director2016 β€” 2026Zurich, Switzerland
  12. Arvelle Therapeutics (Acquired by Angelini Pharma in 2021)Non Executive Director (took over from late Tom Beck)2020 β€” 2021Zug, Switzerland
  13. Orchard Therapeutics (NASDAQ: ORTX) acquired by Kyowa Kirin in 2023Founding CEO, then Non Executive Director2015 β€” 2018London, United Kingdom
  14. Acacia Pharma (EURONEXT BRUSSELS: ACPH) acquired by Eagle Pharmaceuticals in 2022Non Executive Director2013 β€” 2018Cambridge, United Kingdom
  15. AdaptimmuneBoard Observer, Adaptimmune Therapeutics PLC (NASDAQ: ADAP)2015 β€” 2016Oxford, United Kingdom
  16. MVMPartner2005 β€” 2012London and Boston
  17. Gateway FundInvestment Manager2001 β€” 2005Cambridge, United Kingdom
  18. OC&CConsultant1996 β€” 1999London, United Kingdom

Education

  1. University of CambridgePhD, Chemistry1992 β€” 1996
  2. University of CambridgeMaster of Arts (MA), Natural Sciences1989 β€” 1992

Skills & more

Biopharmaceuticals5Biotechnology49Business Development7Business Planning6Business Strategy17Clinical Development2Commercialization4Corporate Development8Corporate Finance3Drug Development1Drug Discovery2Due Diligence13
+12 moreEmerging MarketsEntrepreneurshipFinancial ModelingHealthcareInvestment BankingInvestmentsInvestor RelationsLife SciencesRStrategic PlanningStrategyLifesciences

From Alexander's professional profile.

Same school

Shared employers

Investments

Board seats

Acacia PharmaAdaptimmune TherapeuticsArvelle TherapeuticsCastorGenomics LtdNodthera, Inc.Oviva AGOwkin, Inc.Peptone LtdPulmocide LtdShift Bioscience Ltd

Investor

ARTBIO, Inc.Orchard Therapeutics PLCTenpoint Therapeutics Holdings Ltd

Per the firm's website.

Colleagues at F-Prime Capital Partners

Network14

β–Ά2 more connections

Gaurav TuliMuz Mansuri

Investors connected to Alexander in public investor directories β€” a warm-intro map.